Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stoffregen

Showing results (221-230 of 238) with videos related to

Pageof 24
Sort By:
Circulation. Arrhythmia and Electrophysiology|December 16, 2017
Near-Field Ultrasound Imaging During Radiofrequency Catheter Ablation: Tissue Thickness and Epicardial Wall Visualization and Assessment of Radiofrequency Ablation Lesion Formation and DepthDavid E Haines, Matthew Wright, Erik Harks, et al.
Nature Communications|August 22, 2018
The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradationAnnette Aichem, Samira Anders, Nicola Catone, et al.
Nature Communications|November 4, 2018
Author Correction: The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradationAnnette Aichem, Samira Anders, Nicola Catone, et al.
Animals : an Open Access Journal From MDPI|August 10, 2024
Influences on the Decision to Euthanize a Compromised PigJulia Stoffregen, Tristan Winkelmann, Bettina Schneider, et al.
European Urology|June 30, 2009
Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre studyAndreas Böhle, Herbert Leyh, Christian Frei, et al.
Journal of Medical Internet Research|July 18, 2025
Streamlining a Patchwork - Exploring the Challenges of Digital Transformation in Pathology: Ethnographic StudyBirte Linny Geisler, Ourania Amperidou, Sina Patricia Pauly, et al.
Cancer Research|June 3, 2005
In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutantsThomas O'Hare, Denise K Walters, Eric P Stoffregen, et al.
Leukemia|September 10, 2005
A single nucleotide polymorphism in the coding region of ABL and its effects on sensitivity to imatinibL C Crossman, T O'Hare, T Lange, et al.
Comparative Medicine|January 20, 2004
Clinical and microbiologic characterization of hemorrhagic pneumonia due to extraintestinal pathogenic Escherichia coli in four young dogsLarry K Handt, Dana A Stoffregen, Judith S Prescott, et al.
Molecular and Cellular Biology|August 2, 2006
Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinibIan J Griswold, Mary MacPartlin, Thomas Bumm, et al.
Pageof 24

Showing results (221-230 of 238) with videos related to

Sort By:
Pageof 24
Circulation. Arrhythmia and Electrophysiology|December 16, 2017
Near-Field Ultrasound Imaging During Radiofrequency Catheter Ablation: Tissue Thickness and Epicardial Wall Visualization and Assessment of Radiofrequency Ablation Lesion Formation and DepthDavid E Haines, Matthew Wright, Erik Harks, et al.
Nature Communications|August 22, 2018
The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradationAnnette Aichem, Samira Anders, Nicola Catone, et al.
Nature Communications|November 4, 2018
Author Correction: The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradationAnnette Aichem, Samira Anders, Nicola Catone, et al.
Animals : an Open Access Journal From MDPI|August 10, 2024
Influences on the Decision to Euthanize a Compromised PigJulia Stoffregen, Tristan Winkelmann, Bettina Schneider, et al.
European Urology|June 30, 2009
Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre studyAndreas Böhle, Herbert Leyh, Christian Frei, et al.
Journal of Medical Internet Research|July 18, 2025
Streamlining a Patchwork - Exploring the Challenges of Digital Transformation in Pathology: Ethnographic StudyBirte Linny Geisler, Ourania Amperidou, Sina Patricia Pauly, et al.
Cancer Research|June 3, 2005
In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutantsThomas O'Hare, Denise K Walters, Eric P Stoffregen, et al.
Leukemia|September 10, 2005
A single nucleotide polymorphism in the coding region of ABL and its effects on sensitivity to imatinibL C Crossman, T O'Hare, T Lange, et al.
Comparative Medicine|January 20, 2004
Clinical and microbiologic characterization of hemorrhagic pneumonia due to extraintestinal pathogenic Escherichia coli in four young dogsLarry K Handt, Dana A Stoffregen, Judith S Prescott, et al.
Molecular and Cellular Biology|August 2, 2006
Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinibIan J Griswold, Mary MacPartlin, Thomas Bumm, et al.
Pageof 24